levacetylleucine (Aqneursa)

From Aaushi
Jump to navigation Jump to search

Indications

Dosage

Adverse effects

Mechanism of action

  • unknown

More general terms

References

  1. Monaco K Second Drug OK'd for Ultra-Rare Neurodegenerative Disease. FDA approves levacetylleucine (Aqneursa) for Niemann-Pick disease type C. MedPage Today September 25, 2024 https://www.medpagetoday.com/genetics/generalgenetics/112111

Database